Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 37.87

+33.8%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (362)	5/21/2008 10:56:17 AM
From: scaram(o)uche	of 566

>> up 24% in the last reporting period << OK, so lotsa pukin' shorts all over this stock. Lehman pointed early to the lymphoma results, and the stock went off like a rocket. Do we have anything more than this??.... 1. R406-sensitive DLBCLs can be identified by their transcriptional profiles (Chen et al., Blood. 2008 Feb 15;111(4):2230-7); 2. R788 has significant clinical activity in B-cell non-Hodgkin's lymphoma (Friedberg et al., James P. Wilmot Cancer Centre, University of Rochester); and 3. the meeting report from Birchenough and buds.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next